The HPV vaccine, known by the Merck brand name Gardisil 9, can prevent most cervical and anal cancers in children and young adults exposed to the virus. However, vaccine coverage has remained low at just 50% in the United States. The vaccine is typically administered in two to three doses, but a recent UPI article noted research that suggests it can be just as effective with a single dose, which could encourage more people to get vaccinated.
Quick Hits: The HPV Vaccine May Be More Effective Than We Thought
New research suggests a single dose of the HPV vaccine may provide as much protection from cervical cancer as the recommended two to three doses.
Jan 3, 2020
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
Read More